Interventional oncology at the time of COVID-19 pandemic: Problems and solutions - 29/05/20
Highlights |
• | COVID-19 pandemic modifies in-depth interventional oncology practice. |
• | Identification of aerosol-generating procedures is crucial for safety. |
• | Curative treatment of cancers should not be delayed during the COVID-19 pandemic. |
• | Solutions to overcome shortage in anesthesiology resources are described. |
Abstract |
The COVID-19 pandemic has deeply impacted the activity of interventional oncology in hospitals and cancer centers. In this review based on official recommendations of different international societies, but also on local solutions found in different expert large-volume centers, we discuss the changes that need to be done for the organization, safety, and patient management in interventional oncology. A literature review of potential solutions in a context of scarce anesthesiologic resources, limited staff and limited access to hospital beds are proposed and discussed based on the literature data.
Le texte complet de cet article est disponible en PDF.Keywords : Liver cancer, Interventional radiology, Lung cancer, Kidney cancer, COVID-19
Abbreviations : AASLD, AEGP, ASCO, BCLC, CIRSE, CT, EASL, ESMO, HCC, ICU, IO, IR, MDTB, NHS, OS, PPE, RCC, RFA, rt-PCR, SIRT, TACE
Plan
Vol 101 - N° 6
P. 347-353 - juin 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.